Michael Jaffe v. Samsung Electronics Company

737 F.3d 14
CourtCourt of Appeals for the Fourth Circuit
DecidedDecember 3, 2013
Docket12-1802
StatusPublished
Cited by6 cases

This text of 737 F.3d 14 (Michael Jaffe v. Samsung Electronics Company) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Michael Jaffe v. Samsung Electronics Company, 737 F.3d 14 (4th Cir. 2013).

Opinions

Affirmed by published opinion. Judge NIEMEYER wrote the opinion, in which Judge FLOYD joined. Judge WYNN wrote a separate opinion concurring in Parts I, II, and III and the judgment.

NIEMEYER, Circuit Judge:

This appeal presents the significant question under Chapter 15 of the U.S. Bankruptcy Code of how to mediate between the United States’ interests in recognizing and cooperating with a foreign insolvency proceeding and its interests in protecting creditors of the foreign debtor with respect to U.S. assets, as provided in 11 U.S.C. §§ 1521 and 1522.

Qimonda AG, a German corporation that manufactured semiconductor devices and was, for a brief time, one of the world’s largest manufacturers of dynamic random access memory (“DRAM”), filed for insolvency in Munich, Germany, in January 2009. ‘ The principal assets of Qimonda’s estate consisted of some 10,000 patents, about 4,000 of which were U.S. patents. These patents were subject to cross-license agreements with Qimonda’s competitors, as was common in the semiconductor industry to avoid infringement risks caused by the “patent thicket” resulting from the overlapping patent rights of some 420,000 patents in the semiconductor industry.

Ancillary to the German insolvency proceeding, Dr. Michael Jaffé, the insolvency administrator appointed by the Munich court, filed an application in the Bankruptcy Court for the Eastern District of Virginia under Chapter 15 of the U.S. Bankruptcy Code, petitioning the U.S. court to recognize the German insolvency proceeding as a “foreign main proceeding” in order to obtain an array of privileges available under Chapter 15. Among other relief, Jaffé specifically requested that the bankruptcy court entrust to him, pursuant to 11 U.S.C. § 1521(a)(5), the administration of all of Qimonda’s assets' within the territorial jurisdiction of the United States, which largely consisted of the 4,000 U.S. patents.

Contemporaneously with the Chapter 15 proceeding, Jaffé sent letters to licensees of Qimonda’s patents under its cross-license agreements, declaring that, under § 103 of the German Insolvency Code, the licenses granted under Qimonda patents “are no longer enforceable,” including the licenses under the company’s 4,000 U.S. patents. As Jaffé later indicated to the bankruptcy court, he intended to re-license Qimonda’s patents for the benefit of Qim-onda’s creditors, replacing licenses paid for in-kind with cross-licenses with licenses paid for with cash through royalties.

The bankruptcy court entered an order recognizing the German insolvency pro[18]*18ceeding as a foreign main proceeding and a separate order granting Jaffé the discretionary relief he requested under § 1521(a)(5). But, following a four-day ev-identiary hearing, it conditioned the § 1521 relief with the requirement that Jaffé afford the' licensees of Qimonda’s U.S. patents the treatment they would have received in the United States under 11 U.S.C. § 365(n), which limits a trustee’s ability to reject unilaterally licenses to the debtor’s intellectual property by giving licensees the option to retain their rights under the licenses. After balancing- the interests of Qimonda’s estate with the interests of the licensees of its U.S. patents, the bankruptcy court concluded that the application of § 365(n) was necessary to ensure, as required by § 1522(a), that the licensees were “sufficiently . protected,” even though it would adversely affect Qim-onda’s estate. The bankruptcy court also concluded, pursuant to 11 U.S.C. § 1506, that allowing Jaffé to cancel unilaterally Qimonda’s licenses of U.S. patents “would be manifestly contrary to the public policy of the United States,” recognizing “a fundamental U.S. public policy promoting technological innovation,” which would be undermined if it failed to apply § 365(n) to the licenses under Qimonda’s U.S. patents.

In this direct appeal from the bankruptcy court, Jaffé challenges both of these conclusions, arguing that the court erred in its construction of Chapter 15 and abused its discretion in applying it.

We conclude that the bankruptcy court properly recognized that Jaffé’s request for discretionary relief under § 1521(a) required it to consider “the interests of the creditors and other interested entities, including the debtor” under § 1522(a) and that it properly construed § 1522(a) as requiring the application of a balancing test. Moreover, relying on the particular facts of this case and the extensive record developed during the four-day evidentiary hearing, we also conclude that the bankruptcy court reasonably exercised its discretion in balancing the interests of the licensees against the interests of the debt- or and finding that application of § 365(n) was necessary to ensure the licensees under Qimonda’s U.S. patents were sufficiently protected. Accordingly, we affirm.

I

The German insolvency proceeding

Qimonda AG filed an application to' open a preliminary insolvency proceeding in the Munich Insolvency Court on January 23, 2009, which was converted to a final proceeding on April 1, 2009. Upon converting the proceeding to a final one, the court appointed Dr. Michael Jaffé to serve as the estate’s insolvency administrator, a position akin to a bankruptcy trustee under U.S. law. Subsequently, Qimonda ceased all manufacturing operations and began to liquidate its estate. The principal assets of the estate consisted of its approximately 10,000 patents, including about 4,000 U.S. patents. Most of these patents covered products or processes related to DRAM, but some covered other types of semiconductor technology.

The “patent thicket” and the practice of cross-licensing

At the time Qimonda opened its insolvency proceeding, its patents were subject to numerous cross-license agreements with other semiconductor manufacturers, including Infineon Technologies AG (from which Qimonda had spun off in 2006), Samsung Electronics Company, International Business Machines Corporation (“IBM”), Intel Corporation, Hynix Semiconductor, Inc., Nanya Technology Corporation, and Micron Technology, Inc. While some of these cross-license agreements were designed to facilitate specific joint ventures, [19]*19most simply reflected the strategy widely adopted in the semiconductor industry in response to infringement risks arising from the industry’s “patent thicket” — a term used to describe “a dense web of overlapping intellectual property rights.” Carl Shapiro, Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting, in 1 Innovation Policy and the Economy .119, 120 (Adam B. Jaffé et al. eds., 2001). As the bankruptcy court in this case aptly explained and all parties agreed, there are so many patents implicated by any new semiconductor product that “it would be all but impossible to design around each and every” one. In re Qimonda AG, 462 B.R. 165, 175 (Bankr.E.D.Va.2011). “Indeed, such is the number of potentially applicable patents that it is not always possible to identify which ones' might. cover a, new product....” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
737 F.3d 14, Counsel Stack Legal Research, https://law.counselstack.com/opinion/michael-jaffe-v-samsung-electronics-company-ca4-2013.